Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
Authors
Keywords
-
Journal
International Journal of Environmental Research and Public Health
Volume 18, Issue 4, Pages 2078
Publisher
MDPI AG
Online
2021-02-22
DOI
10.3390/ijerph18042078
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serial KL-6 measurements in COVID-19 patients
- (2021) Miriana d’Alessandro et al. Internal and Emergency Medicine
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic value of C-reactive protein in patients with COVID-19
- (2020) Xiaomin Luo et al. CLINICAL INFECTIOUS DISEASES
- Serum KL‐6 concentrations as a novel biomarker of severe COVID19
- (2020) Miriana d'Alessandro et al. JOURNAL OF MEDICAL VIROLOGY
- Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy
- (2020) Maurizio Cecconi et al. Journal of Clinical Medicine
- Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
- (2020) Fang Liu et al. JOURNAL OF CLINICAL VIROLOGY
- Serum KL‐6 can distinguish between different phenotypes of severe COVID‐19
- (2020) Hideta Nakamura et al. JOURNAL OF MEDICAL VIROLOGY
- Exploration and correlation analysis of changes in Krebs von den Lungen-6 levels in COVID-19 patients with different types in China
- (2020) Mingshan Xue et al. BioScience Trends
- Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
- (2020) Chandan Sarkar et al. Frontiers in Pharmacology
- COVID-19 vaccines: ethical framework concerning human challenge studies
- (2020) Daniela Calina et al. DARU-Journal of Pharmaceutical Sciences
- Serum KL‐6 level is a prognostic marker in patients with anti‐MDA5 antibody‐positive dermatomyositis associated with interstitial lung disease
- (2019) Yan Ye et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease
- (2018) H. Qin et al. Pulmonology
- Comparative Study of Circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as Disease Markers of Idiopathic Pulmonary Fibrosis
- (2016) Kosuke Hamai et al. DISEASE MARKERS
- Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease
- (2016) M. Kuwana et al. JOURNAL OF RHEUMATOLOGY
- Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis
- (2014) Shinichiro Ohshimo et al. RESPIRATORY MEDICINE
- Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer
- (2013) Toshihiko Sato et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- A cohort study of mortality predictors and characteristics of patients with combined pulmonary fibrosis and emphysema
- (2012) Tomoo Kishaba et al. BMJ Open
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started